Search
01/07/2025
Proteomic analysis of Down syndrome cerebrospinal fluid compared to late-onset and autosomal dominant Alzheimers disease
Montoliu-Gaya, L, Bian, SJ, Dammer, EB, Alcolea, D, Sauer, M, Martá-Ariza, M, Ashton, NJ, Belbin, O, Fuchs, J, Watson, CM, Ping, LY, Duong, DM, Nilsson, J, Barroeta, I, Lantero-Rodriguez, J, Videla, L, Benejam, B, Roberts, BR, Blennow, K, Seyfried, NT, Levey, AI, Carmona-Iragui, M, Gobom, J, Lleó, A, Wisniewski, T, Zetterberg, H, Fortea, J, Johnson, ECB. Proteomic analysis of Down syndrome cerebrospinal fluid compared to late-onset and autosomal dominant Alzheimers disease. Nature Communications. 2025; 16(1)DOI:10.1038/s41467-025-61054-z. PMID:40595720. IF:15.700(Q1/1D).
01/07/2025
Medial temporal lobe atrophy in Down syndrome along the Alzheimer's disease continuum
Buehner, BJ, Morcillo-Nieto, AO, Zsadanyi, SE, Aranha, MR, Arriola-Infante, JE, Vaqué-Alcazar, L, Arranz, J, Rodríguez-Baz, I, Blesa, LM, Videla, L, Barroeta, I, Soriano, LD, Benejam, B, Fernández, S, Hernandez, AS, Bargalló, N, González-Ortiz, S, Giménez, S, de Flores, R, Yushkevich, PA, Alcolea, D, Belbin, O, Lleó, A, Carmona-Iragui, M, Fortea, J, Bejanin, A. Medial temporal lobe atrophy in Down syndrome along the Alzheimer's disease continuum. BRAIN. 2025; 148(7)DOI:10.1093/brain/awaf133. PMID:40243675. IF:11.700(Q1/1D).
01/07/2025
Clinical Features of Children With MOG-IgG Who Fulfill Criteria of Multiple Sclerosis and Overlapping Disorders
Fonseca, EG, Olivé-Cirera, G, Chen, LW, Paredes-Carmona, F, Enamorado, NN, Duran, SB, Mendibe, MD, Visa-Reñe, N, Vázquez-López, M, Felipe-Rucián, A, Romeu, G, Martinez-Hernandez, E, Blanco, Y, Sepulveda, M, Saiz, A, Dalmau, J, Armangue, T. Clinical Features of Children With MOG-IgG Who Fulfill Criteria of Multiple Sclerosis and Overlapping Disorders. Neurology-Neuroimmunology & Neuroinflammation. 2025; 12(4)DOI:10.1212/NXI.0000000000200400. PMID:40505071. IF:7.500(Q1/1D).
01/07/2025
Early safety after TAVR according to VARC-3 criteria: incidence, predictors, and clinical impact
Gonzálvez-García, A, Cepas-Guillén, P, Ternacle, J, Urena, M, Alperi, A, Cheema, AN, Veiga-Fernández, G, Nombela-Franco, L, Vilalta, V, Esposito, G, Campelo-Parada, F, Idolfi, C, del Trigo, M, Muñoz-García, A, Maneiro, N, Asmarats, L, Regueiro, A, del Val, D, Serra, V, Auffret, V, Jonveaux, M, Bonnet, G, Mesnier, J, Gaspard, S, Avanzas, P, Rezaei, E, Fradejas-Sastre, V, Tirado-Conte, G, Fernández-Nofrerías, E, Franzone, A, Guitteny, T, Sorrentino, S, Oteo, JF, Díez-Delhoyo, F, Gutiérrez-Alonso, L, Vidal, P, Alfonso, F, Monastyrski, A, Nolf, M, Pelletier-Beaumont, E, Avvedimento, M, Rodés-Cabau, J. Early safety after TAVR according to VARC-3 criteria: incidence, predictors, and clinical impact. REVISTA ESPANOLA DE CARDIOLOGIA. 2025; 78(7)DOI:10.1016/j.rec.2024.12.005. PMID:39722415. IF:4.900(Q1/2D).
01/07/2025
Targeting the pyruvate dehydrogenase kinase/pyruvate dehydrogenase axis modulates neutrophil and smooth muscle cell pathological responses and prevents abdominal aortic aneurysm formation
Griepke, S, Grentzmann, A, Tripodi, GL, Hansen, J, da Fonseca, MP, Nilsson, MD, Tallouzi, Y, Grupe, E, Jensen, PS, Beck, HC, Temprano-Sagrera, G, Sabater-Lleal, M, Burton, M, Dembic, M, Thomassen, M, Forteza, MJ, Terp, MG, Lindholt, JS, Rasmussen, LM, Steffensen, LB, Stubbe, J, Ketelhuth, DFJ. Targeting the pyruvate dehydrogenase kinase/pyruvate dehydrogenase axis modulates neutrophil and smooth muscle cell pathological responses and prevents abdominal aortic aneurysm formation. CARDIOVASCULAR RESEARCH. 2025; 121(8)DOI:10.1093/cvr/cvaf032. PMID:40037693. IF:13.300(Q1/1D).
01/07/2025
Response to the Letter to the Editor regarding "Persistence, effectiveness, and tolerability of anti-calcitonin gene-related peptide monoclonal antibodies in patients with chronic migraine"
de Dios, A, Pagès-Puigdemont, N, Ojeda, S, Riera, P, Pelegrin, R, Morollon, N, Belvís, R, Real, J, Masip, M. Response to the Letter to the Editor regarding "Persistence, effectiveness, and tolerability of anti-calcitonin gene-related peptide monoclonal antibodies in patients with chronic migraine". HEADACHE. 2025; 65(7)DOI:10.1111/head.14983. PMID:40668957. IF:4.000(Q1/2D).
01/07/2025
A Spanish-Portuguese GWAS of progressive supranuclear palsy reveals a novel risk locus in NFASC
García-González, P, Lara, HR, Compta, Y, Fernandez, M, van der Lee, SJ, de Rojas, I, Saiz, L, Painous, C, Camara, A, Muñoz, E, Marti, MJ, Valldeoriola, F, Puerta, R, Illán-Gala, I, Pagonabarraga, J, Dols-Icardo, O, Kulisevsky, J, Fortea, J, Lleó, A, Olivé, C, de Boer, SCM, Hulsman, M, Pijnenburg, YAL, Belloso, RD, Muñoz-Delgado, L, Rueda, DB, Gómez-Garre, P, Aldecoa, I, Aragonés, G, Vara, JH, Mendioroz, M, Pérez-Tur, J, Visser, PJ, den Braber, A, Papma, JM, Montes, AM, Rodriguez-Rodriguez, E, Blázquez-Folch, J, Miguel, A, García-Gutiérrez, F, Cano, A, Valero, S, Marquié, M, Capdevila-Bayo, M, Rosende-Roca, M, Quintela, I, Carracedo, A, Tàrraga, L, Real, LM, Royo, JL, Erro, ME, Guerrero, C, Torres, DC, Blázquez-Estrada, M, San Millán, B, Teijeira, S, Rolan, DV, Hernández, I, Sánchez-Soblechero, A, de la Casa-Fages, B, López, SS, Baviera-Muñoz, R, Lavín, A, Taipa, R, Amer, G, Martinez-Saez, E, Fernández-Matarrubia, M, Lage-Martínez, C, Alvarez, V, Molina-Porcel, L, Holstege, H, Mir, P, Belbin, O, Boada, M, Fernández, V, Bullido, MJ, Rábano, A, Sánchez-Juan, P, Ruiz, A. A Spanish-Portuguese GWAS of progressive supranuclear palsy reveals a novel risk locus in NFASC. EUROPEAN JOURNAL OF HUMAN GENETICS. 2025; 33(7)DOI:10.1038/s41431-025-01872-3. PMID:40379966. IF:4.600(Q1/2D).
01/07/2025
Development and validation of a risk score to predict community-acquired pneumonia occurrence in the adult population
Prat, MS, Cuevas, AL, Ribas, IB, Fanegas, EP, Pujol, JA. Development and validation of a risk score to predict community-acquired pneumonia occurrence in the adult population. Respiratory Investigation. 2025; 63(4)DOI:10.1016/j.resinv.2025.04.012. PMID:40288222. IF:(Q/D).
01/07/2025
The Impact of Rhinovirus, Syncytial Respiratory Virus and Helminth Infection on the Risk of New-Onset Asthma and Other Allergic Conditions-A Systematic Review for the EAACI Guidelines on Environmental Science for Allergic Diseases and Asthma
Agache, I, Salazar, J, Rodriguez-Tanta, Y, Saenz, FKF, Haahtela, T, Traidl-Hoffmann, C, Damialis, A, Vecillas, L, Giovannini, M, Nadeau, KC, Pali-Schöll, I, Palomares, O, Renz, H, Schwarze, J, Pinto, BS, Urrutia-Pereira, M, Venter, C, Vercelli, D, Winders, T, Sola-Arnau, I, Alonso-Coello, P, Canelo-Aybar, C, Jutel, M, Akdis, CA. The Impact of Rhinovirus, Syncytial Respiratory Virus and Helminth Infection on the Risk of New-Onset Asthma and Other Allergic Conditions-A Systematic Review for the EAACI Guidelines on Environmental Science for Allergic Diseases and Asthma. ALLERGY. 2025; 80(7)DOI:10.1111/all.16611. PMID:40495394. IF:12.000(Q1/1D).
01/07/2025
Effects of a Hypotension-Avoidance Versus a Hypertension-Avoidance Strategy on Neurocognitive Outcomes After Noncardiac Surgery
Marcucci, M, Chan, MTV, Painter, TW, Efremov, S, Aguado, HJ, Astrakov, SV, Kleinlugtenbelt, YV, Patel, A, Cata, JP, Amir, M, Kirov, M, Leslie, K, Duceppe, E, Borges, FK, de Nadal, M, Tandon, V, Landoni, G, Likhvantsev, VV, Lomivorotov, V, Sessler, DI, Martínez-Zapata, MJ, Xavier, D, Fleischmann, E, Wang, CY, Meyhoff, CS, Wittmann, M, Torres, D, Highton, D, Jacka, M, Vishwanath, B, Zarnke, K, Sidhu, RS, Oriani, G, Ayad, S, Minear, S, Weaver, TE, Ruetzler, K, Brusasco, C, Parlow, JL, Maxwell, E, Miller, S, Mrkobrada, M, Bhatt, KSC, Rahate, P, Kowark, A, De Blasio, G, Ofori, SN, Conen, D, Srinathan, S, Szczeklik, W, Jayaram, R, Ellerkmann, RK, Momeni, M, Copland, I, Vincent, J, Balasubramanian, K, Li, ZR, Wang, MK, Li, DY, McGillion, MH, Kurz, A, Sharma, M, Short, TG, Devereaux, PJ. Effects of a Hypotension-Avoidance Versus a Hypertension-Avoidance Strategy on Neurocognitive Outcomes After Noncardiac Surgery. ANNALS OF INTERNAL MEDICINE. 2025; 178(7)DOI:10.7326/ANNALS-24-02841. PMID:40456161. IF:15.200(Q1/1D).
01/07/2025
Redefining Omalizumab Discontinuation in Chronic Spontaneous Urticaria: The Value of Optimization and Predictive Factors of Relapse. A 52-Week Multicenter Study
Ceravalls, J, Giménez-Arnau, AM, Exposito-Serrano, V, Chico, NF, Moya, AL, Bielsa, I, Ribó, P, Mascaró-Hereza, B, Bonfill-Orti, M, Spertino, J, Serra, E, Baliu-Piqué, C, Melé-Ninot, G. Redefining Omalizumab Discontinuation in Chronic Spontaneous Urticaria: The Value of Optimization and Predictive Factors of Relapse. A 52-Week Multicenter Study. Actas Dermo-Sifiliograficas. 2025; 116(7)DOI:10.1016/j.ad.2024.08.014. PMID:. IF:(Q/D).
01/07/2025
Association of Plasma Phosphorylated Tau 217 With Clinical Deterioration Across Alzheimer Disease Stages.
Selma-Gonzalez J, Rubio-Guerra S, García-Castro J, Vera-Campuzano E, Sala I, Sánchez-Saudinós MB, Zhu N, Arranz J, Arriola-Infante JE, Rodríguez-Baz Í, Maure-Blesa L, Dols-Icardo O, Videla L, Valldeneu S, Barroeta I, Santos-Santos M, Carmona-Iragui M, Vaqué-Alcázar L, Alvarez-Sanchez E, Lorente O, Carreras M, Belbin O, Arslan B, Ashton NJ, Zetterberg H, Blennow K, Montoliu-Gaya L, Bejanin A, Lleó A, Fortea J, Alcolea D, Illan-Gala I. Association of Plasma Phosphorylated Tau 217 With Clinical Deterioration Across Alzheimer Disease Stages.. NEUROLOGY. 2025; 105(1)DOI:10.1212/WNL.0000000000213769. PMID:40472304. IF:(Q/D).
01/07/2025
Use of ReCross to Increase Success Rate With Antegrade CTO PCI-A Multicenter Observational Study
Ayoub, M, Mozid, A, Philip, L, Millan, X, Khatri, J, Ungureanu, C, Bennett, J, Ghafari, C, Avran, A. Use of ReCross to Increase Success Rate With Antegrade CTO PCI-A Multicenter Observational Study. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. 2025; 106(1)DOI:10.1002/ccd.31585. PMID:40384369. IF:2.100(Q3/6D).
01/07/2025
Clinical management of acute myocarditis in daily practice: an expert practical view
Kerneis, M, Ammirati, E, Delmas, C, Heggermont, W, Heymans, S, Lenz, M, Madonna, R, Morosin, M, Schaubroeck, H, Sionis, A, Tsaban, G, Uzokov, J, Vardanyan, K, Vandenbriele, C, Roubille, F. Clinical management of acute myocarditis in daily practice: an expert practical view. European Heart Journal-Acute Cardiovascular Care. 2025; 14(7)DOI:10.1093/ehjacc/zuaf057. PMID:40198815. IF:4.600(Q1/2D).
01/07/2025
Management of multidrug-resistant gram-negative bacilli infections in adult solid organ transplant recipients: GESITRA-IC/SEIMC, CIBERINFEC, and SET recommendations update.
Rodríguez-Goncer, I, Ruiz-Arabi, E, Herrera, S, Sabé, N, Los-Arcos, I, Silva, JT, Perez-Nadales, E, Machuca, I, Alvarez, R, Valerio, M, Castón, JJ, Aguilera, V, Bodro, M, Cano, A, Cantón, R, Carmona, P, Carratalà, J, Cordero, E, Cruzado, JM, Fariñas, MC, Fernández-Ruiz, M, Fondevila, C, Fortún, J, García-Cosío, MD, Gutiérrez-Dalmau, A, Iturbe, D, Justo, I, Len, O, López-Medrano, F, Oliva, MOL, Martín-Dávila, P, Martínez-Martínez, L, Mazuecos, A, Mirabet, S, Muñoz, P, Oliver, A, Pérez-Sáez, MJ, Rodríguez-Gómez, J, San-Juan, R, Sánchez-Céspedes, J, Solé, A, Verdú, EV, Villa, J, Torre-Cisneros, J, Aguado, JM. Management of multidrug-resistant gram-negative bacilli infections in adult solid organ transplant recipients: GESITRA-IC/SEIMC, CIBERINFEC, and SET recommendations update.. Transplantation Reviews. 2025; 39(3)DOI:10.1016/j.trre.2025.100937. PMID:40414085. IF:2.500(Q1/1D).
01/07/2025
Analytical Interference of Exemestane with Androstenedione Immunoassays
Giralt, M, Ferrer, R, Díaz-Troyano, N, Vega, B, Luque-Ramírez, M, Martínez, S, Fernández, B, Martínez, I, Fabregat, A, Urgell, E, Cardona, I, Casals, G, Escobar-Morreale, HF. Analytical Interference of Exemestane with Androstenedione Immunoassays. Annals of Laboratory Medicine. 2025; 45(4)DOI:10.3343/alm.2024.0362. PMID:40114653. IF:3.900(Q1/1D).
01/07/2025
GLP-1 receptor agonists in obesity treatment: Effects on cardiometabolic variables and cardiovascular disease
Sardà, H, Genua, I, Miñambres, I. GLP-1 receptor agonists in obesity treatment: Effects on cardiometabolic variables and cardiovascular disease. MEDICINA CLINICA. 2025; 165(1)DOI:10.1016/j.medcli.2025.106951. PMID:40378625. IF:2.100(Q2/3D).
01/07/2025
Identification of new therapeutic targets related to endoplasmic reticulum stress and mitochondrial dysfunction to reduce the risk of rupture in degenerative ascending aortic aneurysm
Almendra-Pegueros, R, Barros-Membrilla, AJ, Pérez-Marlasca, E, Julve, J, Martinez-González, J, Rodriguez, C, Galán, M. Identification of new therapeutic targets related to endoplasmic reticulum stress and mitochondrial dysfunction to reduce the risk of rupture in degenerative ascending aortic aneurysm. Clinica E Investigacion En Arteriosclerosis. 2025; 37(4)DOI:10.1016/j.arteri.2024.09.002. PMID:39424523. IF:(Q/D).
01/07/2025
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline
Wyckoff, JA, Lapolla, A, Asias-Dinh, BD, Barbour, LA, Brown, FM, Catalano, PM, Corcoy, R, Di Renzo, GC, Drobycki, N, Kautzky-Willer, A, Murad, MH, Stephenson-Gray, M, Tabák, AG, Weatherup, E, Zera, C, Singh-Ospina, N. Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2025; 193(1)DOI:10.1093/ejendo/lvaf116. PMID:40652450. IF:5.200(Q1/2D).
01/07/2025
The People-First Liver Charter
Lazarus, JV, Wajcman, DI, Pannain, S, Brennan, PN, Manolas, MI, Jepsen, P, Treloar, C, Arora, AK, Matthews, PC, Picchio, CA, White, TM, Grebely, J, Vaz, J, Hagström, H, Rabin, KH, Isaacs, S, Ribeiro, RT, Roden, M, Betel, M, Willemse, J, Díaz, LA, Allen, AM, Alkhouri, N, Schattenberg, JM, Mauricio, D, Rinella, ME, Pose, E, Tsochatzis, EA, Ninburg, M, Cusi, K, Alazawi, W, Duseja, A, Frühbeck, G, Lofton, H, Jaisinghani, P, Kanwal, F, Shiha, G, Zelber-Sagi, S, Holden, L, Villota-Rivas, M. The People-First Liver Charter. NATURE MEDICINE. 2025; 31(7)DOI:10.1038/s41591-025-03759-8. PMID:40473951. IF:50.000(Q1/1D).